Chlorpromazine Metabolism in Chronic Schizophrenics
- 1 December 1971
- journal article
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 119 (553) , 589-596
- https://doi.org/10.1192/bjp.119.553.589
Abstract
At present the phenothiazine drugs constitute the medication of choice in the treatment of schizophrenia. While in most schizophrenics treatment with phenothiazines does ameliorate the symptoms of the disease there are a certain number of patients who remain resistant to therapy. In such patients the side effects caused by phenothiazines may also be less pronounced or completely absent.Keywords
This publication has 8 references indexed in Scilit:
- DISTRIBUTION AND FATE OF MORPHINE IN NON-TOLERANT AND TOLERANT DOGS AND RATSThe Journal of Pharmacology and Experimental Therapeutics, 2025
- Distribution of chlorpromazine metabolites in selected organs of psychiatric patients chronically dosed up to the time of deathBiochemical Pharmacology, 1968
- Long-Term Chlorpromazine Retention and Its Modification by SteroidsAmerican Journal of Psychiatry, 1968
- Determination of nanogram quantities of chlorpromazine and some of its metabolites in plasma by using gas-liquid chromatography with an electron capture detectorAnalytical Chemistry, 1968
- Withdrawal effects of phenothiazinesComprehensive Psychiatry, 1965
- Lenticular and Corneal Opacities During Phenothiazine TherapyJAMA, 1965
- Factors Influencing Spectrofluorometry of Phenothiazine Drugs.Analytical Chemistry, 1964
- Spectrofluorometric Identification of Phenothiazine Drugs.Analytical Chemistry, 1963